UPL publishes Q1FY27 earnings call transcript with management commentary
UPL Limited published the transcript of its earnings conference call held on August 3, 2026, detailing Q1FY27 financial results. The company reported consolidated revenue of ₹10,181 crore, up 10% YoY, and EBITDA of ₹1,500 crore, up 15% YoY. Management highlighted strong segment performance and maintained FY27 guidance for 7-11% revenue growth.

*this image is generated using AI for illustrative purposes only.
UPL Limited has made the transcript of its earnings conference call available to investors, offering detailed insights into the company’s first-quarter FY27 performance. The call was conducted on August 3, 2026, immediately following the Board of Directors’ meeting that approved the unaudited consolidated and standalone financial results for the quarter ended June 30, 2026. This disclosure allows stakeholders to review management’s specific commentary on the reported 10% year-on-year revenue rise to ₹10,181 crore and the 15% increase in EBITDA to ₹1,500 crore.
The release of the transcript was communicated pursuant to Regulation 30 read with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sandeep Mohan Deshmukh, Company Secretary and Compliance Officer of UPL Limited, signed off on the intimation sent to BSE Limited and National Stock Exchange of India Ltd. The filing directs investors to the company’s official website where the transcript can be accessed under the financial results section.
Key Consolidated Financial Highlights
The approved results for Q1FY27 reflect broad-based growth across UPL’s platforms and regions. Revenue from operations stood at ₹10,181 crore, up from ₹9,216 crore in the corresponding period of the previous year. EBITDA expanded by 15% to ₹1,500 crore, with margins improving by 60 basis points to 14.7%. Net debt remained stable at $2.5 billion.
| Metric: | Q1FY27 | Q1FY26 | Change (YoY) |
|---|---|---|---|
| Revenue: | ₹10,181 Cr | ₹9,216 Cr | +10% |
| EBITDA: | ₹1,500 Cr | ₹1,304 Cr* | +15% |
| EBITDA Margin: | 14.7% | 14.1%* | +60 bps |
| Net Debt: | $2.5 Bn | $2.5 Bn | Flat |
Note: Prior year figures derived from YoY % change stated in source.
Segment Performance and Guidance
Growth was driven by strong performances in Advanta (+26%) and SUPERFORM (+14%). UPL Corporation Ltd saw revenue rise 7% to ₹6,374 crore, with EBITDA surging 38% to ₹532 crore. For the full year FY27, UPL has guided for revenue growth of 7–11% and EBITDA growth of 10–14%, signaling continued confidence in its "Accelerating Profitable Growth" strategy.
| Guidance Metric: | FY27 Target |
|---|---|
| Revenue Growth: | 7–11% |
| EBITDA Growth: | 10–14% |
Corporate Developments
The Composite Scheme of Arrangement, approved by the Board on February 20, 2026, remains under progress. This scheme involves amalgamating UPL Sustainable Agri Solutions Limited into UPL Limited and demerging the India Crop Protection business. The Competition Commission of India approved the scheme on June 2, 2026. Further approvals from shareholders, regulators, and the National Company Law Tribunal (NCLT) are pending. No accounting effect has been recognized for the scheme in Q1FY27.
What the Numbers Show
The divergence between rising revenue (10%) and stable debt levels suggests improved cash conversion efficiency, even as working capital days increased to 110 days from 86 days in the prior year. The significant EBITDA growth in UPL Corp (38%) compared to its modest revenue growth (7%) indicates successful margin optimization strategies in key international markets. The FY27 EBITDA growth guidance of 10–14%, outpacing the revenue growth guidance of 7–11%, further underscores management's focus on margin expansion as a core strategic priority.
Historical Stock Returns for UPL
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.74% | +5.22% | -2.18% | -5.89% | -18.47% | -15.39% |
How might the pending NCLT and shareholder approvals for the Composite Scheme of Arrangement impact UPL's operational integration timeline and FY27 cost synergies?
Given the 24-day increase in working capital days to 110, what specific measures is management implementing to prevent further cash flow constraints amidst rising revenue?
Can the margin expansion observed in UPL Corporation be sustained across other segments like Advanta and SUPERFORM, or are there regional risks that could dilute overall EBITDA growth?


































